The Incoming Influenza Season - China, the United Kingdom, and the United States, 2021-2022

被引:17
|
作者
Han, Shasha [1 ,2 ]
Zhang, Ting [3 ]
Lyu, Yan [4 ]
Lai, Shengjie [5 ]
Dai, Peixi [6 ]
Zheng, Jiandong [6 ]
Yang, Weizhong [3 ]
Zhou, Xiaohua [1 ,7 ,8 ]
Feng, Luzhao [3 ]
机构
[1] Peking Univ, Beijing Int Ctr Math Res, Beijing, Peoples R China
[2] Harvard Univ, Harvard Med Sch, Boston, MA 02115 USA
[3] Chinese Acad Med Sci & Peking Union Med Coll, Sch Populat Med & Publ Hlth, Beijing, Peoples R China
[4] Peking Univ, Acad Adv Interdisciplinary Studies, Beijing, Peoples R China
[5] Univ Southampton, Sch Geog & Environm Sci, WorldPop, Southampton, Hants, England
[6] Chinese Ctr Dis Control & Prevent, Div Infect Dis, Beijing, Peoples R China
[7] Peking Univ, Sch Publ Hlth, Dept Biostat, Beijing, Peoples R China
[8] Peking Univ, Natl Engn Lab Big Data Anal & Appl Technol, Beijing, Peoples R China
来源
CHINA CDC WEEKLY | 2021年 / 3卷 / 49期
基金
比尔及梅琳达.盖茨基金会;
关键词
COVID-19;
D O I
10.46234/ccdcw2021.253
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Introduction: Seasonal influenza activity has declined globally since the widespread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) transmission. There has been scarce information to understand the future dynamics of influenza - and under different hypothesis on relaxation of non pharmaceutical interventions (NPIs) in particular - after the disruptions to seasonal patterns. Methods: We collected data from public sources in China, the United Kingdom, and the United States, and forecasted the influenza dynamics in the incoming 2021-2022 season under different NPIs. We considered Northern China and Southern China separately, due to the sharp difference in the patterns of seasonal influenza. For the United Kingdom, data were collected for England only. Results: Compared to the epidemics in 2017-2019, longer and blunter influenza outbreaks could occur should NPIs be fully lifted, with percent positivity varying from 10.5 to 18.6 in the studying regions. The rebounds would be smaller if the mask wearing intervention continued or the international mobility stayed low, but sharper if the mask-wearing intervention was lifted in the middle of influenza season. Further, influenza activity could stay low under a much less stringent mask-wearing intervention coordinated with influenza vaccination. Conclusions: The results added to our understandings of future influenza dynamics after the global decline during the coronavirus disease 2019 (COVID-19) pandemic. In light of the uncertainty on the incoming circulation strains and the relatively low negative impacts of mask wearing on society, our findings suggested that wearing mask could be considered as an accompanying mitigation measure in influenza prevention and control, especially for seasons after long periods of low-exposure to influenza viruses. Seasonal influenza activity declines globally during the during the coronavirus disease 2019 (COVID-19) pandemic (1-4). For instance, in China, influenza activity, as measured by percentage of submitted specimens testing positive, dropped from 11.8% to 2.0% in 2020-2021 influenza season, compared to the past 5 years (5). The long-period of low-exposure to influenza viruses adds great uncertainty on preparedness for the incoming 2021-2022 influenza season. Influenza vaccination is one of the most effective measures in seasonal influenza prevention and control, but with only a few influenza viruses circulating, it could be difficult to determine the targeted strains for vaccination. In this context, it is of primary importance to identify alternative mitigation measures for the incoming 2021-2022 influenza season, the first season after long periods of virtually no influenza outbreaks worldwide. Using data from China, the United Kingdom, and the United States, we forecasted the influenza activity in the incoming 2021-2022 influenza season under hypothetical scenarios without non-pharmaceutical interventions (NPIs) and with different assumptions on mask-wearing and mobility levels.
引用
下载
收藏
页码:1039 / 1045
页数:7
相关论文
共 50 条
  • [1] Influenza Vaccine Effectiveness Against Influenza A(H3N2)-Related Illness in the United States During the 2021-2022 Influenza Season
    Price, Ashley M.
    Flannery, Brendan
    Talbot, H. Keipp
    Grijalva, Carlos G.
    Wernli, Karen J.
    Phillips, C. Hallie
    Monto, Arnold S.
    Martin, Emily T.
    Belongia, Edward A.
    McLean, Huong Q.
    Gaglani, Manjusha
    Mutnal, Manohar
    Geffel, Krissy Moehling
    Nowalk, Mary Patricia
    Tartof, Sara Y.
    Florea, Ana
    McLean, Callie
    Kim, Sara S.
    Patel, Manish M.
    Chung, Jessie R.
    CLINICAL INFECTIOUS DISEASES, 2023, 76 (08) : 1358 - 1363
  • [2] Telemedicine Use Among Adults with Asthma in the United States, 2021-2022
    Hung, Chun-Tse
    Hung, Yu-Chien
    TELEMEDICINE AND E-HEALTH, 2024, 30 (06) : 1580 - 1587
  • [3] Multiple lineages of monkeypox virus detected in the United States, 2021-2022
    Gigante, Crystal M.
    Korber, Bette
    Seabolt, Matthew H.
    Wilkins, Kimberly
    Davidson, Whitni
    Rao, Agam K.
    Zhao, Hui
    Smith, Todd G.
    Hughes, Christine M.
    Minhaj, Faisal
    Waltenburg, Michelle A.
    Theiler, James
    Smole, Sandra
    Gallagher, Glen R.
    Blythe, David
    Myers, Robert
    Schulte, Joann
    Stringer, Joey
    Lee, Philip
    Mendoza, Rafael M.
    Griffin-Thomas, Latoya A.
    Crain, Jenny
    Murray, Jade
    Atkinson, Annette
    Gonzalez, Anthony H.
    Nash, June
    Batra, Dhwani
    Damon, Inger
    McQuiston, Jennifer
    Hutson, Christina L.
    McCollum, Andrea M.
    Li, Yu
    SCIENCE, 2022, 378 (6619) : 560 - 564
  • [4] Tobacco Education in Doctor of Pharmacy Programs in the United States (2021-2022)
    Hudmon, Karen Suchanek
    Lahey, Alexa M.
    Czarnik, Julia S.
    Elkhadragy, Nervana
    Corelli, Robin L.
    AMERICAN JOURNAL OF PHARMACEUTICAL EDUCATION, 2023, 87 (11)
  • [5] Influenza Activity and Composition of the 2022-23 Influenza Vaccine - United States, 2021-22 Season
    Merced-Morales, Angiezel
    Daly, Peter
    Abd Elal, Anwar Isa
    Ajayi, Noreen
    Annan, Ekow
    Budd, Alicia
    Barnes, John
    Colon, Arielle
    Cummings, Charisse N.
    Iuliano, A. Danielle
    DaSilva, Juliana
    Dempster, Nick
    Garg, Shikha
    Gubareva, Larisa
    Hawkins, Daneisha
    Howa, Amanda
    Huang, Stacy
    Kirby, Marie
    Kniss, Krista
    Kondor, Rebecca
    Liddell, Jimma
    Moon, Shunte
    Nguyen, Ha T.
    O'Halloran, Alissa
    Smith, Catherine
    Stark, Thomas
    Tastad, Katie
    Ujamaa, Dawud
    Wentworth, Dave E.
    Fry, Alicia M.
    Dugan, Vivien G.
    Brammer, Lynnette
    MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT, 2022, 71 (29): : 913 - 919
  • [6] Trichomoniasis and retesting in Durham County, North Carolina, United States, 2021-2022
    Jenks, Jeffrey D.
    Ryan, Emily
    Stancil, Candy
    Harris, Kimberly
    Hester, Lizeth
    Carrico, Savannah
    Mortiboy, Marissa
    Zitta, John-Paul
    INTERNATIONAL JOURNAL OF STD & AIDS, 2024, 35 (06) : 412 - 417
  • [7] Influenza Vaccine for 2021-2022
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2021, 63 (1634): : 153 - 157
  • [8] Salmonella Vitkin Outbreak Associated with Bearded Dragons, Canada and United States, 2021-2022
    Paphitis, Katherine
    Habrun, Caroline A.
    Stapleton, G. Sean
    Reid, Alexandra
    Lee, Christina
    Majury, Anna
    Murphy, Allana
    McClinchey, Heather
    Corbeil, Antoine
    Kearney, Ashley
    Benedict, Katharine
    Tolar, Beth
    Forrest, Russell O.
    EMERGING INFECTIOUS DISEASES, 2024, 30 (02) : 225 - 233
  • [9] An estimate of lifetime incidence of abortion in the United States using the 2021-2022 Abortion Patient Survey
    Jones, Rachel K.
    CONTRACEPTION, 2024, 135
  • [10] Descriptive and molecular epidemiology of leishmaniasis diagnosed from clinical samples in the United States, 2021-2022
    Truong, Thao T.
    Crawford, Karissa
    Wang-McGuire, Ichih
    Jensen, Kendal
    Mushtaq, Aisha
    Lieberman, Nicole A. P.
    Buckner, Frederick S.
    Van Voorhis, Wesley C.
    Cookson, Brad T.
    Salipante, Stephen J.
    Lieberman, Joshua A.
    MICROBIOLOGY SPECTRUM, 2024,